Patient Perspectives on Dupilumab Therapy for Atopic Dermatitis: Experiences, Expectations and Treatment Impact [0.03%]
特应性皮炎患者对Dupilumab治疗的体验、期望和疗效观点
Nadine Abu-Ghazaleh,Gayle Ross,Vanessa Morgan
Nadine Abu-Ghazaleh
Background: Atopic dermatitis (AD) is a chronic inflammatory skin disease characterised by epidermal barrier dysfunction and type 2 immune dysregulation. Dupilumab was the first biologic approved for severe AD and has tra...
Oral Roflumilast in Lichen Planus: A Prospective Real-World Case Series of Ten Adults [0.03%]
罗氟司特口服治疗扁平苔藓：10例成人真实世界病例系列研究
Francisco José Navarro-Triviño,David Moyano-Bueno,José María Llamas-Molina et al.
Francisco José Navarro-Triviño et al.
Lichen planus (LP) is a chronic inflammatory dermatosis with limited systemic treatment options, and prospective data on oral phosphodiesterase-4 (PDE4) inhibition are lacking. We conducted a prospective real-world case series of ten adults...
Ilse Andrea Moreno-Arquieta,Héctor Teodoro Rios-Bazaldua,Roger Adrián González-Ramírez et al.
Ilse Andrea Moreno-Arquieta et al.
Monkeypox (mpox) is a viral infection characterized by polymorphic cutaneous lesions and systemic symptoms, including fever, lymphadenopathy, headache and myalgia. Given its broad differential diagnosis, accurate recognition requires a high...
Evidence Gaps in Prediction Tools for Follow Up After Localised Melanoma [0.03%]
关于局部期黑色素瘤术后复发预测工具的证据缺口
Deonna M Ackermann,Xu Huang,Ellie Medcalf et al.
Deonna M Ackermann et al.
A Case of Severe Face and Neck Rosacea-Like Pustular Eruption Associated With Upadacitinib in the Treatment of Severe Atopic Dermatitis [0.03%]
乌帕替尼治疗重度特应性皮炎所致严重类似酒渣鼻的面部和颈部脓疱疹1例
Aimal Fatima,Genevieve Casey
Aimal Fatima
Embedding Dermatology in a Constrained Curriculum: A Vertically Integrated, Needs-Driven Model Aligned to Junior Doctor Preparedness [0.03%]
适应限制性课程的皮肤科嵌入式教学：一种与低年级医生准备程度相契合的纵向整合、需求驱动模型
Matthew J Verheyden,Jessica Bulluss,Chon-Wai Jeremy Chan et al.
Matthew J Verheyden et al.
Cutaneous Adverse Events in Children Receiving Mitogen-Activated Protein Kinase Pathway Inhibitors [0.03%]
儿童使用MAPK通路抑制剂的皮肤不良反应
Yuong Chin Tan,Santosh Valvi,Nicholas G Gottardo et al.
Yuong Chin Tan et al.
Background/objective: Mitogen-activated protein kinase pathway inhibitors (MAPKi) are increasingly used as targeted therapies for paediatric central nervous system tumours and other malignancies. Cutaneous toxicities, inc...
Annabelle Yi Zhang,Dug Yeo Han,Paul Jarrett
Annabelle Yi Zhang
Introduction: The prevalence of adolescent and adult atopic eczema (AE) in New Zealand is not known. This study estimates the prevalence and epidemiology in Auckland, New Zealand, from 2017 to 2019, before the COVID-19 pa...
Real-World Persistence of Upadacitinib for Atopic Dermatitis: Expanded Analysis From Royal Melbourne Hospital Biogrid Registry and the Australasian Dermatology Registry [0.03%]
乌帕替尼治疗特应性皮炎的现实世界持久性：来自皇家墨尔本医院生物数据库和澳大利亚皮肤病学登记处的扩展分析
Nadine Abu-Ghazaleh,Julie Armstrong,Vanessa Morgan et al.
Nadine Abu-Ghazaleh et al.
Real-World Outcomes and Safety of JAK Inhibitors in Paediatric Alopecia Areata: A Retrospective Multicentre Study [0.03%]
一项关于儿童斑秃的回顾性多中心研究：JAK抑制剂的真实世界疗效及安全性
Miguel Mansilla-Polo,Aniza Giacaman,Carlos Abril-Pérez et al.
Miguel Mansilla-Polo et al.
Introduction: Alopecia areata (AA) is a non-scarring, immune-mediated hair loss disorder with substantial psychosocial impact in children. Robust paediatric real-world evidence regarding Janus kinase inhibitors (JAKi) for...